Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoembolization”

505 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 505 results

Not applicableStudy completedNCT01360255
What this trial is testing

AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)

Who this might be right for
Hepatocellular Carcinoma
University Hospital Freiburg 70
Large-scale testing (Phase 3)Study completedNCT02973685
What this trial is testing

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 315
Large-scale testing (Phase 3)UnknownNCT02338297
What this trial is testing

Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

Who this might be right for
Carcinoma, Hepatocellular
Nanjing Medical University 236
Early research (Phase 1)UnknownNCT01721941
What this trial is testing

TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Scripps Clinic Cancer Center 20
Not applicableStudy completedNCT00926536
What this trial is testing

Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance

Who this might be right for
Carcinoma, Hepatocellular
Stanford University 84
Not applicableUnknownNCT04523467
What this trial is testing

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 320
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Not applicableUnknownNCT00518557
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

Who this might be right for
Hepatocellular Carcinoma
Southeast University, China 60
Testing effectiveness (Phase 2)Looking for participantsNCT06261814
What this trial is testing

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Who this might be right for
Liver Neoplasms
john eisenbrey 266
Large-scale testing (Phase 3)Study completedNCT04103398
What this trial is testing

TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaSorafenibTransarterial Chemoembolization
Sun Yat-sen University 162
Not applicableUnknownNCT06194695
What this trial is testing

DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Ze-yang Ding, MD 100
Not applicableNot Yet RecruitingNCT07109336
What this trial is testing

Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 790
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Testing effectiveness (Phase 2)Ended earlyNCT02958163
What this trial is testing

Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)

Who this might be right for
Liver NeoplasmsHepatocellular Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 3
Testing effectiveness (Phase 2)Study completedNCT00844233
What this trial is testing

Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Boston Scientific Corporation 40
Not applicableUnknownNCT04161287
What this trial is testing

Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE

Who this might be right for
Small Hepatocellular CarcinomaStereotactic Body Radiation TherapyTranscatheter Arterial Chemoembolization
Beijing 302 Hospital 330
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Not applicableWithdrawnNCT04231929
What this trial is testing

BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

Who this might be right for
Hepatocellular Carcinoma
Terumo Europe N.V.
Not applicableStudy completedNCT04721470
What this trial is testing

Combined Therapy for Hepatocellular Carcinoma >3-<5 cm

Who this might be right for
Hepatocellular Carcinoma
Zagazig University 278
Not applicableWithdrawnNCT03172559
What this trial is testing

Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto
Load More Results